PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of needle-free drug delivery systems, today announced that it has entered into a Term Loan and Security Agreement with Partners for Growth, L.P. (“PFG”) for a $500,000 term loan. The loan is due in twelve equal monthly installments commencing October 1, 2007 and ending September 1, 2008. In connection with the loan agreement, the Company issued a warrant to PFG to purchase 71,429 shares of its common stock at a price of $1.40 per share.
